Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 6/20 | 0.52 |
| ▸ | BRAF | P15056 | 8/20 | 0.52 |
| ▸ | PDE4A | P27815 | 5/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.51 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.41 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4900838 | 0.89 | BRAF (0.43) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL4908318 | 0.87 | BRAF (0.57) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL4900820 | 0.87 | LHCGR (0.51) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL4904239 | 0.85 | BRAF (0.68) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL4908611 | 0.84 | BRAF (0.53) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL14281432 | 0.83 | BRAF (0.77) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL4908199 | 0.83 | BRAF (0.70) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL6110243 | 0.80 | IKBKB (0.64) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL14281657 | 0.77 | BRAF (0.68) | IKBKBBRAFPDE4APDE4BPDE4C | |
| SCHEMBL14281751 | 0.77 | BRAF (0.59) | IKBKBBRAFPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080004271-A1 | Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith | MCKENNA JEFFREY M | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004271-A1 | Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewith | PDE4A, PDE4B, BRAF | IKBKB 361/4885BRAF 3/4885PDE4A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.